These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32867051)

  • 21. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin.
    Li J; Guo Y; Li H; Shang L; Li S
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1085-1094. PubMed ID: 28776393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chiral mesoporous silica based LOFL delivery systems using achiral alcohols as co-structure-directing agents: Construction, characterization, sustained release and antibacterial activity.
    Cui M; Xie L; Zhang S; Chen L; Xi Y; Wang Y; Guo Y; Xu L
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110483. PubMed ID: 31522027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
    Feng Y; Liao Z; Li M; Zhang H; Li T; Qin X; Li S; Wu C; You F; Liao X; Cai L; Yang H; Liu Y
    Adv Healthc Mater; 2023 Jun; 12(16):e2201884. PubMed ID: 36529877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
    Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
    Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Templating mesoporous silica with chiral block copolymers and its application for enantioselective separation.
    Gabashvili A; Medina DD; Gedanken A; Mastai Y
    J Phys Chem B; 2007 Sep; 111(38):11105-10. PubMed ID: 17727283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enantiomer self-disproportionation of chiral compounds on achiral ordered mesoporous silica M41S and regular silica gel as a stationary phase.
    Mayani VJ; Abdi SH; Kureshy RI; Khan NH; Agrawal S; Jasra RV
    Chirality; 2009 Feb; 21(2):255-61. PubMed ID: 18561251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of teicoplanin-modified hybrid magnetic mesoporous silica nanoparticles and their application in chiral separation of racemic compounds.
    Wu J; Su P; Huang J; Wang S; Yang Y
    J Colloid Interface Sci; 2013 Jun; 399():107-14. PubMed ID: 23541694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesoporous silica nanoparticles in nanomedicine applications.
    Manzano M; Vallet-Regí M
    J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights.
    Vallet-Regí M; Colilla M; Izquierdo-Barba I; Manzano M
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29295564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multichiral Mesoporous Silica Screws with Chiral Differential Mucus Penetration and Mucosal Adhesion for Oral Drug Delivery.
    Wang Y; Li W; He Z; Yin W; Chen X; Zhang J; Li H
    ACS Nano; 2024 Jun; 18(25):16166-16183. PubMed ID: 38867485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silica materials in drug delivery applications.
    Simovic S; Ghouchi-Eskandar N; Sinn AM; Losic D; Prestidge CA
    Curr Drug Discov Technol; 2011 Sep; 8(3):269-76. PubMed ID: 21291408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immobilization of chiral oxazaborolidine catalyst over highly ordered 3D mesoporous silica with Ia3d symmetry for enantioselective reduction of prochiral ketone.
    Velmathi S; Balakrishnan U; Ananthi N; Aldeyab SS; Ariga K; Naidu TS; Vinu A
    Phys Chem Chem Phys; 2011 Mar; 13(11):4950-6. PubMed ID: 21327233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly ordered chiral inorganic mesoporous material used as stationary phase for high-resolution gas chromatographic separations.
    Li YX; Fu SG; Zhang JH; Xie SM; Li L; He YY; Zi M; Yuan LM
    J Chromatogr A; 2018 Jul; 1557():99-106. PubMed ID: 29739613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chiral Pd-Catalyzed Enantioselective Syntheses of Various N-C Axially Chiral Compounds and Their Synthetic Applications.
    Kitagawa O
    Acc Chem Res; 2021 Feb; 54(3):719-730. PubMed ID: 33481580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L- and D-proline adsorption by chiral ordered mesoporous silica.
    Casado C; Castán J; Gracia I; Yus M; Mayoral A; Sebastián V; López-Ram-de-Viu P; Uriel S; Coronas J
    Langmuir; 2012 Apr; 28(16):6638-44. PubMed ID: 22475019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helical mesoporous silica as an inorganic heterogeneous chiral trigger for asymmetric autocatalysis with amplification of enantiomeric excess.
    Kawasaki T; Araki Y; Hatase K; Suzuki K; Matsumoto A; Yokoi T; Kubota Y; Tatsumi T; Soai K
    Chem Commun (Camb); 2015 May; 51(42):8742-4. PubMed ID: 25803308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.